• Site Selections for Tuberculosis Clinical Trials

    2 monthes ago - By The Healthcare Guys

    Authored by Janis Brix, CEO Wigwam
    With over 25 years of experience as a CRO and expertise in TB clinical research, Dokumeds has an elaborate network with key stakeholders and clinical sites in TB burden countries and in-depth knowledge of their regulatory framework. The 15 years of dedicated work and experience have enabled Dokumeds to develop a comprehensive risk assessment approach for TB trials site selection. Our experience traverses across multiple realms, including multidrug resistant , pre-extensively drug-resistant , extensively drug-resistant , and HIV-associated TB. Dokumeds...
    Read more ...